• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Finance

Providers

CVS closing in on deal to buy Oak Street Health: WSJ

The Wall Street Journal reported Monday that CVS is closing in on a deal to buy Oak Street Health at a price of about $39 a share.
Heather Landi Feb 6, 2023 10:02pm

Wyden pledges to defend drug price negotiation powers

Feb 6, 2023 4:50pm

Amazon's One Medical deal faces increased scrutiny: report

Feb 6, 2023 12:12pm

ShiftMed banks $200M to scale up its nurse staffing solution

Feb 6, 2023 9:01am

Alabama hospitals' margin declines dwarf nationwide losses

Feb 6, 2023 7:25am

DOJ tosses 'outdated' healthcare antitrust enforcement policies

Feb 3, 2023 4:00pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy